for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Innovent Biologics' FY Total Revenue RMB1,047.5 Mln

March 30 (Reuters) - Innovent Biologics Inc:

* FY TOTAL REVENUE WAS RMB1,047.5 MILLION VERSUS RMB9.5 MILLION

* FY LOSS AND TOTAL COMPREHENSIVE EXPENSES FOR YEAR RMB1.72 BILLION VERSUS LOSS OF RMB 5.87 BILLION

* EXPECT TO SUBMIT AN IND APPLICATION FOR IBI-323 TO NMPA IN ADVANCED CANCER IN 2020 Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up